Human Growth Hormone (hGH) Market to Reach $5.56 Bn, Globally, by 2026 at 8.6% CAGR, Says Allied Market Research

PORTLAND, Oregon, Dec. 9, 2019 /PRNewswire/ -- Allied Market Research published a report, titled, "Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2026." As per the report, the global human growth hormone industry was estimated at $2.84 billion in 2018 and is expected to hit $5.56 billion by 2026, growing at a CAGR of 8.6% from 2019 to 2026.

Drivers, restraints and opportunities-

Rise in usage of growth hormone to control aging and increase in disorders related to growth hormone deficiency drive the growth of the global human growth hormone (hGH) market. On the other hand, several side effects associated with the treatment curtail down the growth to some extent. However, surge in awareness toward usage of human growth hormone in developing economies is expected to create a plethora of lucrative opportunities in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5557

The turner syndrome segment to lead the trail by 2026-

Based on application, the turner syndrome segment held the major share in 2018, generating nearly one-third of the global human growth hormone (hGH) market. Surge in incidence of Turner syndrome propels the growth of the segment. The growth hormone deficiency segment, on the other hand, would cite the fastest CAGR of 9.9% throughout 2019–2026. Rise in growth hormone deficiency across the globe contributes to the market growth of this segment.

The subcutaneous segment held the lion's share in 2017-

Based on route of administration, the subcutaneous segment contributed to nearly two-thirds of the global human growth hormone market (hGH) share in 2018, and is expected to dominate during the study period. The same segment would also showcase the fastest CAGR of 9.1% by 2026. This is due to increased bioavailability of the hormone.

North America to rule the roost throughout the forecast period-

Based on geography, North America accounted for nearly half of the global human growth hormone market (hGH) revenue in 2018, and is projected to rule the roost throughout the estimated period. Easy availability of recombinant human growth hormone, higher number of target population, and favorable reimbursement in healthcare system are the factors propelling the market growth in this province. At the same time, the Asia-Pacific region is predicted to grow at the fastest CAGR of 10.2% during the forecast period. Rise in awareness of growth hormone consumption for improving physique, and rise in disposable income as well as healthcare expenditure drive the market growth in this region.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5557

Key market players-

• Eli Lilly and Company
• Merck & Co., Inc.
• Ferring BV.
• Pfizer Inc.
• F. Hoffmann-La Roche
• Teva Pharmaceutical Industries Ltd.
• Novo Nordisk
• Novartis AG
• AnkeBio Co. Ltd.
• Ipsen

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.

Similar Reports:

Potential Analysis of Human DNA Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

miRNA Tools and Services Market - Global Opportunity Analysis and Industry Forecast, 2017-2025

Teleradiology Market - Global Opportunity Analysis and Industry Forecast, 2017-2025

Electrosurgery Devices Market - Global Opportunity Analysis and Industry Forecast, 2017-2025

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Web: www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Follow Us on Twitter: https://twitter.com/marketresearcht

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg